Given the profound influence of the TME on ICI resistance in HCC, targeting immunosuppressive pathways such as TGF-β and WNT/β-catenin represents a promising strategy to enhance the effectiveness of immunotherapy. Here, TGFB1 is linked to hepatocellular carcinoma.